ReviewBiology2018
Applications of Microalgal Biotechnology for Disease Control in Aquaculture.
Review in Biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 104 citations in OpenAlex.
- Combined and Individual Effects ofAnimals : an open access journal from MDPI · 2026Article
- Microalgae-based aquafeeds for penaeid shrimp: progress toward improved growth, immune modulation, and sustainable production.Veterinary research communications · 2026Review
- Supplementing the diet of Nile tilapia (Oreochromis niloticus) with microalgae Nannochloropsis oculata and Phaeodactylum tricornutum enhanced immune function, lipid profile, and resistance to Edwardsiella tarda infection.Veterinary research communications · 2026Article
- Enhancing vibriosis vaccination in fish: genetically modified Nannochloropsis sp. as an oral vaccine carrier.World journal of microbiology & biotechnology · 2026Article
- RNA Interference Applied to Crustacean Aquaculture.Biomolecules · 2024Review
- New dienelactone hydrolase from microalgae bacterial community-Antibiofilm activity against fish pathogens and potential applications for aquaculture.Scientific reports · 2024Article
- Efficacy of polyvalent vaccine on immune response and disease resistance against streptococcosis/lactococcosis and yersiniosis in rainbow trout (Oncorhynchus mykiss).Veterinary research communications · 2023Article
- Edible microalgae: potential candidate for developing edible vaccines.Vegetos (Bareilly, India) · 2023Review
- Spray Drying Is a Viable Technology for the Preservation of Recombinant Proteins in Microalgae.Microorganisms · 2023Article
- The role of microalgae culture modes in aquaculture: a brief opinion.Frontiers in bioengineering and biotechnology · 2023Article
- Aquaculture sustainability through alternative dietary ingredients: Microalgal value-added products.Engineering microbiology · 2022Review
- Simultaneous Production of a Virus-Like Particle Linked to dsRNA to Enhance dsRNA Delivery for Yellow Head Virus Inhibition.Viruses · 2022Article
- Production of a viral surface protein in Nannochloropsis oceanica for fish vaccination against infectious pancreatic necrosis virus.Applied microbiology and biotechnology · 2022Article
- Revalorization of Microalgae Biomass for Synergistic Interaction and Sustainable Applications: Bioplastic Generation.Marine drugs · 2022Review
- Assessment of the Effects of Edible Microalgae in a Canine Gut Model.Animals : an open access journal from MDPI · 2022Article
- Two Foreign Antimicrobial Peptides Expressed in the Chloroplast ofMarine drugs · 2022Article
- Health benefits of microalgae and their microbiomes.Microbial biotechnology · 2022Review
- Effects ofAntioxidants (Basel, Switzerland) · 2022Article
- Harnessing the Algal Chloroplast for Heterologous Protein Production.Microorganisms · 2022Review
- Current status and development prospects of aquatic vaccines.Frontiers in immunology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aquaculture industries, and in particular the farming of fish and crustaceans, are major contributors to the economy of many countries and an increasingly important component in global food supply. However, the severe impact of aquatic microbial diseases on production performance remains a challenge to these industries. This article considers the potential applications of microalgal technology in the control of such diseases. At the simplest level, microalgae offer health-promoting benefits as a nutritional supplement in feed meal because of their digestibility and high content of proteins, lipids and essential nutrients. Furthermore, some microalgal species possess natural anti-microbial compounds or contain biomolecules that can serve as immunostimulants. In addition, emerging genetic engineering technologies in microalgae offer the possibility of producing 'functional feed additives' in which novel and specific bioactives, such as fish growth hormones, anti-bacterials, subunit vaccines, and virus-targeted interfering RNAs, are components of the algal supplement. The evaluation of such technologies for farm applications is an important step in the future development of sustainable aquaculture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.